000168559 001__ 168559
000168559 005__ 20240229133611.0
000168559 0247_ $$2doi$$a10.1161/ATVBAHA.120.315698
000168559 0247_ $$2pmid$$apmid:33910372
000168559 0247_ $$2ISSN$$a0276-5047
000168559 0247_ $$2ISSN$$a1049-8834
000168559 0247_ $$2ISSN$$a1079-5642
000168559 0247_ $$2ISSN$$a1524-4636
000168559 0247_ $$2ISSN$$a2330-9180
000168559 0247_ $$2ISSN$$a2330-9199
000168559 0247_ $$2altmetric$$aaltmetric:104942783
000168559 037__ $$aDKFZ-2021-00976
000168559 041__ $$aEnglish
000168559 082__ $$a610
000168559 1001_ $$aLangnau, Carolin$$b0
000168559 245__ $$aPlatelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.
000168559 260__ $$aStanford, Calif.$$bHighWire$$c2021
000168559 3367_ $$2DRIVER$$aarticle
000168559 3367_ $$2DataCite$$aOutput Types/Journal article
000168559 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1625060211_24032
000168559 3367_ $$2BibTeX$$aARTICLE
000168559 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168559 3367_ $$00$$2EndNote$$aJournal Article
000168559 500__ $$a2021 Jun;41(6):2080-2096
000168559 520__ $$aPatients with coronary artery disease (CAD) are at increased risk for cardiac death and respiratory failure following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Platelets are crucially involved in pathogenesis of CAD and might also contribute to pathophysiology of SARS-CoV-2 infection. Approach and Results: We enrolled a cohort of 122 participants from February 2020 to July 2020 including 55 patients with preexisting CAD and acute SARS-CoV-2 infection (CAD-SARS-CoV-2positive), 28 patients with CAD and without SARS-CoV-2 (CAD-SARS-CoV-2negative), and 39 healthy controls. Clinical and cardiac examination of the CAD-SARS-CoV-2positive group included blood sampling, echocardiography, and electrocardiography within 24 hours after hospital admission. Phenotyping of platelets was performed by flow cytometry; plasma levels of chemokines were analyzed by ELISA. Respiratory failure of patients was stratified by the Horovitz index as moderately/severely impaired when Horovitz index <200 mm Hg. The clinical end point was defined as Horovitz index <200 mm Hg with subsequent mechanical ventilation within a follow-up of 60 days. CAD-SARS-CoV-2positive patients display a significant enhanced platelet activation and hyper-inflammation early at time of hospital admission. Circulating platelet/leukocyte co-aggregates correlate with plasma levels of cytokines/chemokines like IL (interleukin)-6, CCL2, and CXCL10 as well as activation of platelets is associated with CCL5 and elevation of pulmonary artery pressure. Furthermore, furin is stored and released from activated platelets. High furin plasma levels are associated with poor clinical prognosis in CAD-SARS-CoV-2positive patients.Patients with CAD and SARS-CoV-2 infection exhibit elevated systemic platelet activation and enhanced plasma levels of the subtilisin-like proprotein convertase furin, which may contribute to an unfavorable clinical prognosis.
000168559 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000168559 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000168559 650_7 $$2Other$$acoronary artery disease
000168559 650_7 $$2Other$$acytokines
000168559 650_7 $$2Other$$aflow cytometry
000168559 650_7 $$2Other$$afurin
000168559 650_7 $$2Other$$apulmonary artery
000168559 7001_ $$aRohlfing, Anne-Katrin$$b1
000168559 7001_ $$aGekeler, Sarah$$b2
000168559 7001_ $$0P:(DE-He78)b676990c2f64e3295740d42e356fb053$$aGünter, Manina$$b3$$udkfz
000168559 7001_ $$aPöschel, Simone$$b4
000168559 7001_ $$aPetersen-Uribe, Álvaro$$b5
000168559 7001_ $$aJaeger, Philippa$$b6
000168559 7001_ $$aAvdiu, Alban$$b7
000168559 7001_ $$aHarm, Tobias$$b8
000168559 7001_ $$aKreisselmeier, Klaus-Peter$$b9
000168559 7001_ $$aCastor, Tatsiana$$b10
000168559 7001_ $$aBakchoul, Tamam$$b11
000168559 7001_ $$aRath, Dominik$$b12
000168559 7001_ $$aGawaz, Meinrad Paul$$b13
000168559 7001_ $$0P:(DE-He78)d3dbba28fe1239effd15962787cbc363$$aAutenrieth, Stella E$$b14$$udkfz
000168559 7001_ $$aMueller, Karin Anne Lydia$$b15
000168559 773__ $$0PERI:(DE-600)1494427-3$$a10.1161/ATVBAHA.120.315698$$gp. ATVBAHA.120.315698ATVBAHA.120.315698$$n6$$p2080-2096$$tArteriosclerosis, thrombosis, and vascular biology$$v41$$x1524-4636$$y2021
000168559 909CO $$ooai:inrepo02.dkfz.de:168559$$pVDB
000168559 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b676990c2f64e3295740d42e356fb053$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000168559 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d3dbba28fe1239effd15962787cbc363$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000168559 9130_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000168559 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000168559 9141_ $$y2021
000168559 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2021-02-03$$wger
000168559 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-02-03$$wger
000168559 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bARTERIOSCL THROM VAS : 2019$$d2021-02-03
000168559 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bARTERIOSCL THROM VAS : 2019$$d2021-02-03
000168559 9201_ $$0I:(DE-He78)F171-20160331$$kF171$$lDentritische Zellen bei Infektionen und Krebs$$x0
000168559 980__ $$ajournal
000168559 980__ $$aVDB
000168559 980__ $$aI:(DE-He78)F171-20160331
000168559 980__ $$aUNRESTRICTED